Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Kidney Int. 2013 Jul 17;84(6):1108–1118. doi: 10.1038/ki.2013.276

Figure 1. Schematic outlining evidence-based investigation of traditional Chinese herbal medications (TCHM).

Figure 1

Future studies are required to identify active compounds from TCHM, and determine their molecular mechanism of action. Well-designed animal studies and randomized clinical trials are needed to validate the physiological and pathological roles of these agents for treatment of patients with kidney disease. Complementary use of western and eastern medicines for treatment of kidney disease will also need to be further defined and proven.